Oracle Corp., the world's second- largest software maker, agreed to buy Phase Forward Inc. for about $685 million to add clinical-trial software and services that help drug companies develop products and ensure safety.
50570
Oracle agrees to buy Phase Forward for $685 million
162385
Oracle to buy Secerno to add security applications
53167
BMC to buy BladeLogic for about $800 million
127657
Oracle to acquire network virtualisation technology provider Xsigo Systems
65172
Bank of America buys Merrill Lynch
88430
Drugstore.com acquired by Walgreens
112080
Solutia initiates stock offering
91902
Pfizer buys rival drugmaker Wyeth for $68 billion
115435
Oracle expands presence in oil and gas industry
72794
Applied Signal Technology, Inc. enters into agreement to be acquired by Raytheon Company
95158
Oracle buys Art technology Group
154583
Nasdaq OMX Group completes acquisition of Boston Stock Exchange
47482
Dell to buy Quest software for $2.4 billion
136747
Pfizer to buy Wyeth for $68 billion;
71566
Hologic agrees to buy Gen-Probe for about $3.72 billion
81072
Oracle donates openoffice to the Apache software Foundation
79929
Google acquires G.co